ArticleMolecular pharmaceutics2015

CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia.

Hong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.